Search
forResearch 10 of 1000+
- Alopecia and hair repigmentation associated with anti-programmed death-ligand 1 (PD-L1) immunotherapy
- LB1681 Risk of merkel cell carcinoma progression after treatment discontinuation in patients with an objective response to anti-PD-(L)1 immunotherapy
- Anti-programmed cell death protein 1-induced lichenoid changes of the nail unit: Histopathologic description
- Cutaneous Side Effects of Modern Targeted Therapy and Immunotherapy in Patients with Dermatological Malignancies
- Age-associated inflammation connects RAS-induced senescence to stem cell dysfunction and epidermal malignancy
- Immune-related alopecia (areata and universalis) in cancer patients receiving immune checkpoint inhibitors
- N6-methyladenosine RNA Methylation Correlates with Immune Microenvironment and Immunotherapy Response of Melanoma
- Role of the SOX family in cancer immune evasion: Emerging player and promising therapeutic opportunities
- Global trends in tertiary lymphoid structures: a bibliometric analysis from 2014 to 2023
- 183 PD-1 regulatory network is upregulated in contact immunotherapy during alopecia areata treatment
Learn
— no results
Try a deeper search in learn →Community
— no results
Try a deeper search in community →